Whalegun
Lobbying

Mayne Pharma Commercial's latest lobbying report covers Q1 2026, at $40K. The four quarters Q4 2025–Q3 2026 total $70K. Its first report covers Q1 2025; the issues it reports most are Health Issues.

Mayne Pharma Commercial

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$70K
Last 4 quarters
vs last quarter
No record
Q3 2026 against the quarter before
First report
Q1 2025
The first quarter a report named it

Lobbying by quarter

Mayne Pharma Commercial lobbying by quarter
Mayne Pharma Commercial lobbying by quarter
QuarterAmountReports
Q1 2025$10K1
Q2 2025$20K1
Q3 2025$40K1
Q4 2025$30K1
Q1 2026$40K1
Q2 2026$00
Q3 2026$00

By issue

  • Health issues$140K · 5 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • HOUSE OF REPRESENTATIVES5 reports
  • SENATE5 reports
  • Health & Human Services, Dept of (HHS)3 reports
  • Labor, Dept of (DOL)3 reports
  • Treasury, Dept of3 reports

Firms it paid

Firm
Keefe Strategies LLC Fka Keefe Singiser Partners$100K4 quarters
Singiser Solutions$40K1 quarters

Former officials lobbying for it

Former position
DANA SINGISERSpecial Assistant to the President, The White House; Staff Director, Senate Democratic Steering and Outreach CommitteeQ1 2026
DANA SINGISERSpecial Assistant to the President, The White House; Staff Director, Senate Democratic Steering and Outreach CommitteeQ4 2025

Lobbying reports

Filed by
04/20for Q1Singiser Solutions$40K
01/15for Q1Singiser SolutionsUnder $5,000
01/15for Q4 2025Keefe Strategies LLC Fka Keefe Singiser Partners$30K
25/10/16for Q3 2025Keefe Strategies LLC Fka Keefe Singiser Partners$40K
25/07/18for Q2 2025Keefe Strategies LLC Fka Keefe Singiser Partners$20K
25/04/10for Q1 2025Keefe Strategies LLC Fka Keefe Singiser Partners$10K
25/04/09for Q1 2025Keefe Strategies LLC Fka Keefe Singiser PartnersUnder $5,000